By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



35 Ehad Ha-Am Street

  Tel-Aviv  65202   Israel
Phone: n/a Fax: n/a


Company News
Alcobra (ADHD) Discusses New Market Research And Updates On Recent Corporate Events At Investor Forum In New York City 7/17/2014 6:57:53 AM
Alcobra (ADHD) Completes Patient Recruitment In Phase 3 Clinical Trial Of MDX In Adult ADHD 7/14/2014 6:22:52 AM
Alcobra (ADHD) To Host Investor Forum And Webcast On July 15 In New York City 7/7/2014 8:26:04 AM
Alcobra (ADHD) To Provide Corporate Overview At The JMP Securities Healthcare Conference 6/17/2014 8:46:38 AM
Alcobra (ADHD) To Present At The American Society Of Clinical Psychopharmacology Annual Meeting And The Biotechnology Industry Organization (BIO) International Convention 6/9/2014 9:04:29 AM
Alcobra (ADHD) To Provide Corporate Overview At The Jefferies and Co. 2014 Global Healthcare Conference 5/27/2014 9:12:07 AM
Alcobra (ADHD) To Present At The Gordon Research Conference On Fragile X And Autism-Related Disorders 5/23/2014 11:00:17 AM
Alcobra (ADHD) Announces First Quarter Financial Results And Corporate Update 5/15/2014 11:40:45 AM
Alcobra (ADHD) Presents Evidence Of Novel Mechanism Of Action For Metadoxine Extended Release (MDX) In Cognitive Disorders At The Society Of Biological Psychiatry Annual Meeting 5/12/2014 10:00:26 AM
Alcobra (ADHD) Announces FDA Clearance Of Protocol For Phase 2b Study Of Metadoxine Extended Release (MDX) In The Treatment Of Fragile X Syndrome 5/8/2014 12:06:52 PM